Trial intelligence / Profile preview

IPACK Block vs. ACB Alone for Pain After Total Knee Arthroplasty

NCT03921034Phase 4Completed

Sponsor
Ochsner Clinic Foundation
Start
Nov 2016
Primary completion
Jan 2018
Modality
Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
01

Overview

A Phase 4 trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain, sponsored by Ochsner Clinic Foundation. Started Nov 2016; status: completed.

02

Drugs

ropivacaine hydrochloride liposomal suspension injection
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03921034.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03921034.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call